Skip to content
Menu

Bausch Health Companies Inc. BHC

Full chart Compare
Set alert

Price alert · BHC

All alert types
8.22 USD -0.34 (-3.97%)

Regular-session close

8.18 -0.04 -0.49%

After hours · Nov 20, 5:52 PM ET

8.12 Day range 8.56
4.33 52-week range 9.04
YTD
+18.27%
1 year
+37.00%

5D +0.34 (+4.14%)

8.208.408.608.80FriMonTueWedThu8.56
Market cap
3.08B
Revenue (ttm)
11.11B
Profit margin
-7.57%
EPS (ttm)
-2.26
Shares out
374.27M
Forward P/E
1.90
YTD return
+18.27%
1-year return
+37.00%
50-day average
6.75
200-day average
5.85
Volume
3.84M
Avg volume
3.17M
Open
8.42
Previous close
8.56
Day's range
8.12 – 8.56
52-week range
4.33 – 9.04
Beta
0.28
Analysts
Hold
Price target
8.40 (+2.2%)
Earnings date
Feb 17, 2027

Key statistics

Enterprise value
22.42B
PEG ratio
0.01
Price / sales
0.28
Revenue growth
9.70%
Free cash flow
1.64B
Total cash
2.48B
Total debt
20.71B
Return on equity
-11040.00%
Short % of float
2.47%

Fundamental scorecard

6 of 25 checks passed on BHC’s reported financials

ValueGrowthProfitabilityHealthDividend

6of 25 checks passed

  • Value 2 of 5
  • Growth 3 of 5
  • Profitability 0 of 5
  • Financial health 1 of 5
  • Dividend 0 of 5

Statements to Sep 30, 2026.

Financials — quick view

All financials
BHC Revenue — quarterly 2.94B
BHC Net income — quarterly 436.00M
BHC EPS — quarterly 1.16

Earnings

BHC recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 17, 2027Dec 30, 20261.35———
Oct 28, 2026Sep 30, 20261.251.77+0.52+41.60%
Jul 29, 2026Jun 30, 20260.961.26+0.30+31.25%
Apr 29, 2026Mar 31, 20260.810.78-0.03-3.70%
Feb 18, 2026Dec 31, 20251.211.08-0.13-10.74%
Oct 29, 2025Sep 30, 20251.071.16+0.09+8.41%

Upgrades / downgrades

BHC analyst upgrades and downgrades
DateFirmActionFromTo
Nov 11, 2026BarclaysmainEqual-WeightEqual-Weight
Oct 29, 2026JefferiesmainHoldHold
Oct 29, 2026RBC CapitalmainSector PerformSector Perform
Apr 27, 2026RBC CapitalmainSector PerformSector Perform
Feb 25, 2026BarclaysmainEqual-WeightEqual-Weight
Jan 7, 2026Truist SecuritiesmainHoldHold

About Bausch Health Companies Inc.

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, Czech Republic, Slovakia, Ukraine, Bulgaria, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
Canada

News

Your note

Sign in to keep a note on BHC — it syncs with the Stock Master app.

Insider holders

BHC insider holders
InsiderRelationLatest transactionDateShares held
APPIO THOMAS JChief Executive OfficerStock Award(Grant)Feb 24, 20263,620,030
CARSON SEANA LYNNEGeneral CounselSaleMar 2, 2026616,761
CHARHON JEAN-JACQUESChief Financial OfficerStock Award(Grant)Feb 24, 2026755,538
KAVANAGH SARAH BALDWINDirectorStock Award(Grant)May 21, 2026282,230
LENAR AIMEE JOfficerSaleAug 18, 2026334,853
MILLER STEVEN DDirectorStock Award(Grant)May 15, 2025239,224

Institution ownership

BHC institution ownership
Holder% heldSharesValueReported
PAULSON & CO. INC.19.57%73,255,869602.53MSep 29, 2026
Goldentree Asset Management LP9.26%34,665,731285.13MSep 29, 2026
Royal Bank of Canada2.45%9,187,08075.56MSep 29, 2026
Goldman Sachs Group Inc2.07%7,748,37863.73MSep 29, 2026
Vanguard Capital Management LLC1.99%7,444,58961.23MSep 29, 2026
Two Sigma Investments, LP1.98%7,410,21560.95MSep 29, 2026

Fund ownership

BHC fund ownership
Holder% heldSharesValueReported
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund1.00%3,762,19230.94MJul 30, 2026
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund0.66%2,481,31320.41MJun 29, 2026
SCHWAB STRATEGIC TRUST-Schwab Fundamental International Equity ETF0.43%1,617,41213.30MAug 30, 2026
VANGUARD Intl Eqy. INDEX Fd.S-Vanguard FTSE All-World ex-US Small-Cap 0.26%986,0668.11MJul 30, 2026
DFA INVESTMENT TRUST CO-The Canadian Small Company Series0.22%815,0106.70MJul 30, 2026
DFA INVESTMENT DIMENSIONS GROUP INC-Intl Core Eqy. 2 PORT.0.16%594,5114.89MJul 30, 2026